4.7 Review

Nicotinic acetylcholine receptors at the single-channel level

期刊

BRITISH JOURNAL OF PHARMACOLOGY
卷 175, 期 11, 页码 1789-1804

出版社

WILEY
DOI: 10.1111/bph.13770

关键词

-

资金

  1. Agencia Nacional de Promocion Cientifica y Tecnologica de Argentina
  2. Consejo Nacional de Investigaciones Cientificas y Tecnicas Argentina (CONICET)
  3. Universidad Nacional del Sur
  4. Bill and Melinda Gates Foundation
  5. NIH [NS31744, NS94124]
  6. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031744, R01NS031744, R01NS094124] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Over the past four decades, the patch clamp technique and nicotinic ACh (nACh) receptors have established an enduring partnership. Like all good partnerships, each partner has proven significant in its own right, while their union has spurred innumerable advances in life science research. A member and prototype of the superfamily of pentameric ligand-gated ion channels, the nACh receptor is a chemo-electric transducer, binding ACh released from nerves and rapidly opening its channel to cation flow to elicit cellular excitation. A subject of a Nobel Prize in Physiology or Medicine, the patch clamp technique provides unprecedented resolution of currents through single ion channels in their native cellular environments. Here, focusing on muscle and 7 nACh receptors, we describe the extraordinary contribution of the patch clamp technique towards understanding how they activate in response to neurotransmitter, how subtle structural and mechanistic differences among nACh receptor subtypes translate into significant physiological differences, and how nACh receptors are being exploited as therapeutic drug targets.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据